Seda Baykal-Köse (Seda Baykal)

Years Active: 2018-2020
Publications (10 Years): 2

Dokuz Eylul University Medical School

Dokuz Eylul Universitesi Tip Fakultesi (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Dokuz Eylul University Medical School Mar 10 2009

Turkey

Research Assistant :: Medical Biology and Genetics

Education History

Dokuz Eylul Universitesi Tip Fakultesi Sep 08 2010 - Feb 13 2018

Turkey

PHD :: Medical Biology and Genetics

Publications

Seda Baykal-Köse, Eda Acikgoz, Ahmet Sinan Yavuz, Öykü Gönül Geyik, Halil Ateş, Osman Uğur Sezerman, Güner Hayri Özsan, Zeynep Yüce
Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells. PloS one 15 (2) (2020)
Melanie Gentil, Patricia Hugues, Christophe Desterke, Gladys Telliam, Ivan Sloma, Lucas Eduardo Botelho de Souza, Seda Baykal-Köse, Jerome Artus, Frank Griscelli, Agnes Guerci, Hyacinthe Johnson-Ansah, Adlen Foudi, Annelise Bennaceur-Griscelli, Ali G Turhan
Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML). PloS one 13 (8) (2018)

Seda Baykal-Köse.css-eqlu8i{font-size:small;padding-left:4px;} (Seda Baykal)